Beckley Psytech announced that the first cohort of volunteers has been dosed in a clinical trial exploring the safety of their novel formulation of intranasal 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT).
Category Press Release
Beckley Psytech announced that the first cohort of volunteers has been dosed in a clinical trial exploring the safety of their novel formulation of intranasal 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT).